Eribulin and irinotecan for refractory or recurrent Ewing sarcoma: A retrospective study.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.e23502
Abstract: e23502 Background: The effectiveness of eribulin and irinotecan in treatment of xenograft models of Ewing sarcoma is well-established but little clinical data has been reported. Encouraging results from preclinical models and a shortage of temozolomide… read more here.
Keywords: eribulin irinotecan; recurrent ewing; ewing sarcoma; portion ... See more keywords